TPST - Tempest Therapeutics Inc Company Long-Term Liabilities

Public company logo of Tempest Therapeutics Inc (TPST)

The future of Tempest Therapeutics (TPST) depends on the outcomes of joint tests with a major partner and the rate of cash burn. Production capacity is based on the full utilization of research centers and reserved contractor capacities. This price chart featuring the 0.00 indicator complements the analysis, while the company's environmental profile relies on the minimization of water resources and strict purification of laboratory emissions.

tempesttx.com (TPST) Company Long-Term Debt: for the period 07/04/2022 - 10/29/2026

Tempest Tx (TPST) - metric breakdowns and financial figures

- share price and expert price forecast:
Share Price tempesttx.com|TPST - Analyst Consensus Forecast
- market capitalization statistics:
Market Valuation Tempest Therapeutics|TPST - Enterprise Value
- shareholders' equity book value data:
Net Asset Value per Share Tempest Therapeutics|TPST - Company Book Value|Market Value to Book Value tempesttx.com|TPST - Cumulative Company Assets
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Tempest Therapeutics|TPST - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Tempest Therapeutics Corp|TPST - Company Total Debt|Debts to Book Capitalization Tempest Therapeutics|TPST - Company Long-Term Debt|Company Short-Term Loans and Borrowings Tempest Therapeutics
Fundamental company valuation:TPST (tempesttx.com)
Brand item of Tempest Therapeutics

Long-term debt reflects the total credit obligations with a maturity of more than one year, characterizing a business's ability to attract capital resources for strategic development without immediate pressure on liquidity. For Tempest Therapeutics (TPST), analyzing the volume of the issuer's long-term liabilities is critical, as borrowed capital funds costly metabolism inhibitor trials, determining the company's financial stability until patient survival is confirmed.

Competitors of Tempest Therapeutics (TPST)

ONC: Company Long-Term Indebtedness|Halozyme - Company Long-Term Debts|Revolution Medicines Inc (RVMD) - Company Long-Term Liabilities|AAPG: Company Long-Term Debts|Long-Term Debt CG Oncology Therapeutics (CGON)|Company Long-Term Debt UroGen Pharma Ltd.|BCAX: Company Long-Term Loans and Borrowings|Company Long-Term Liabilities PSNL (Personalis)|ERAS (Erasca Inc) - Company Long-Term Loans and Borrowings|Company Long-Term Debts DCTH (Delcath)|YMAB - Company Long-Term Liabilities|AURA: Company Long-Term Liabilities|CADL - Company Long-Term Debts|Accuray (ARAY) - Company Long-Term Debt|SELLAS Life Sciences Group - Company Long-Term Loans and Borrowings|ACTU (Actuate Therapeutics, Inc) - Company Long-Term Debts|Long-Term Debt Citius Oncology Inc CTOR|Company Long-Term Liabilities HURA (TuHURA Biosciences, Inc.)|Amount of Long-Term Liabilities TARA|Company Long-Term Debts FATE (Fate Therapeutics)|Aadi Bioscience, Inc. (WHWK) - Long-Term Debt|TCRX - Company Long-Term Debt|Champions Oncology (CSBR) - Company Long-Term Liabilities|xbiotech.com (XBIT) - Company Long-Term Debt|Long-Term Liabilities CVM (CEL-SCI)|OSTX (OS Therapies) - Company Long-Term Debts|Long-Term Debt Radiopharm Theranostics Ltd RADX|Company Long-Term Debt Artiva Biotherapeutics, Inc. (ARTV)|Long-Term Debt Volume adlainortye.com|Veru Inc. - Company Long-Term Liabilities|Amount of Long-Term Liabilities XLO (Xilio Therapeutics Inc)|RENB: Company Long-Term Liabilities|Company Long-Term Loans and Borrowings MURA (Mural Oncology plc)|KAPA (kairospharma.com) - Company Long-Term Liabilities|OKUR: Amount of Long-Term Liabilities|GDTC (CytoMed Therapeutics Ltd) - Company Long-Term Debts|CRIS: Company Long-Term Loans and Borrowings|Company Long-Term Debts APLM|THAR - Long-Term Debt|Company Long-Term Debt Advanced Biomed ADVB|Company Long-Term Loans and Borrowings GNPX|Calidi Bio - Company Long-Term Debts|SBFM - Company Long-Term Debts|xeneticbio.com (XBIO) - Company Long-Term Debt|Long-Term Liabilities SLRX (Salarius Pharmaceuticals Inc)|PPBT (Purple Biotech Corp) - Company Long-Term Debts|Long-Term Debt AON AONC|Company Long-Term Liabilities BGNE (BeiGene, Ltd.)|Company Long-Term Debts checkpointtx.com (CKPT)|Elevation Oncology, Inc. - Company Long-Term Liabilities|Amount of Long-Term Liabilities ICAD (iCAD Inc.)|Ikena - Company Long-Term Debts|Long-Term Debt Volume Notable Labs Corp NTBL|VIRX: Company Long-Term Debts|Company Long-Term Liabilities morphosys.com|Company Long-Term Debt NAYA Biosciences Inc.|Ascentage Pharma Group International (AAPGV) - Long-Term Debt Volume